Orthocell welcomes globally recognised nerve surgeons to advisory board
Melbourne, Victoria
|
March 30, 2023 03:30 PM Eastern Daylight Time
Orthocell Ltd (ASX:OCC) MD Paul Anderson tells Proactive the company has appointed two internationally recognised orthopaedic surgeons specialising in nerve transfer and peripheral nerve repair, Professor Christopher Dy and Professor David Brogan, to the company’s Medical Scientific Advisory Board (MSAB). Professors Dy and Brogan are based at Washington University and Barnes-Jewish Orthopedic Center, one of the US’s leading academic research institutions and hospitals, and have been appointed to assist with clinical development and US market access for Orthocell’s nerve repair medical device.
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744
